Why TGTX Stock Is Rallying Today - Yahoo Finance

12 hours ago · The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, …

9%
OFF

Why TGTX Stock Is Rallying Today - Yahoo Finance

2 weeks from now

12 hours ago · The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, …

yahoo.com

$10
OFF

TG Therapeutics Price Target Raised To $10 From $9 At BofA

2 weeks from now

Jan 7, 2025 · BofA raised the firm’s price target on TG Therapeutics (TGTX) to $10 from $9 and keeps an Underperform rating on the shares. While political and rate uncertainty continues to …

yahoo.com

30%
OFF

TG Therapeutics Stock Just Rallied 30%: What Happened? - MSN

2 weeks from now

TG Therapeutics Inc (NASDAQ: TGTX) is up 30% on Wednesday even though it reported a wider-than-expected per-share loss for its fiscal first quarter. The biotech stock is being …

msn.com

41%
OFF

TG Therapeutics (TGTX) Stock Sinks As Market Gains: What

2 weeks from now

Mar 24, 2023 · In the latest trading session, TG Therapeutics (TGTX) closed at $14.70, marking a -1.41% move from the previous day.

yahoo.com

49%
OFF

Are Robust Financials Driving The Recent Rally In TG ... - Yahoo …

2 weeks from now

Sep 19, 2024 · Most readers would already be aware that TG Therapeutics' (NASDAQ:TGTX) stock increased significantly by 49% over the past three months. Since the market usually pay …

yahoo.com

8%
OFF

What's Going On With TG Therapeutics Stock Tuesday?

2 weeks from now

1 day ago · TGTX Price Action: TG Therapeutics shares were up 7.8% at $29.85 at the time of publication, according to Benzinga Pro. Photo: Shutterstock. Market News and Data brought to …

benzinga.com

9%
OFF

Why TGTX Stock Is Rallying Today - InvestingChannel News

2 weeks from now

1 day ago · The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, …

investingchannel.com

8%
OFF

Does TG Therapeutics (TGTX) Have The Potential To Rally

2 weeks from now

Nov 6, 2023 · The average of price targets set by Wall Street analysts indicates a potential upside of 127.8% in TG Therapeutics (TGTX). While the effectiveness of this highly sought-after …

yahoo.com

10%
OFF

Why TGTX Stock Is Rallying Today - MSN

2 weeks from now

The Price Action of TG Stock. In the last month the shares have fallen 10%, despite today's rally. However, they have advanced 23% in the previous three months.

msn.com

151%
OFF

Does TG Therapeutics (TGTX) Have The Potential To Rally 151% As …

2 weeks from now

Nov 16, 2022 · TG Therapeutics (TGTX) closed the last trading session at $8.81, gaining 54.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price …

yahoo.com

FAQs about Why TGTX Stock Is Rallying Today - Yahoo Finance Coupon?

Is TG Therapeutics (tgtx) a good stock to buy today?

Among the best stocks to watch, biotech leader TG Therapeutics is clearing a key resistance area on the stock market today. On June 20, 2024, Director Sagar Lonial executed a significant transaction by selling 25,933 shares of TG Therapeutics Inc (NASDAQ:TGTX). The shares were sold at a price of $16.69 each, as detailed in the SEC Filing. ...

Why are TG Therapeutics (tgtx) shares climbing 9% today?

The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, Briumvi. Briumvi's 2024 Revenue Exceeded TG's Guidance The company estimated today that its 2024 revenue from the MS treatment had come in at $310 million. ...

Why did TG Therapeutics stock crash Monday?

TG Therapeutics stock crashed Monday after missing profit expectations, though sales of its multiple sclerosis treatment beat forecasts. TG Therapeutics (TGTX) delivered earnings and revenue surprises of -50% and 4.46%, respectively, for the quarter ended September 2024. ...

Why is TG Therapeutics stock up 30% on Wednesday?

TG Therapeutics Inc (NASDAQ: TGTX) is up 30% on Wednesday even though it reported a wider-than-expected per-share loss for its fiscal first quarter. Why is TG Therapeutics stock up today? The biotech stock is being rewarded primarily because the revenue printed at $63.47 million versus analysts at $54.61 million. ...

Why did TG Therapeutics stock rise 49%?

Most readers would already be aware that TG Therapeutics' (NASDAQ:TGTX) stock increased significantly by 49% over the... TG Therapeutics stock rose Wednesday after the company unveiled promising five-year test results for its multiple sclerosis drug, Briumvi. ...

Does TG Therapeutics stock pay a dividend?

In January, $TGTX acquire a worldwide license for Azer-cel as Invezz reported here. Wall Street currently has a consensus “overweight” rating on TG Therapeutics shares that do not pay a dividend at writing. The post TG Therapeutics stock just rallied 30%: what happened? appeared first on Invezz ...